New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management

New data presented at ATTD demonstrates the system’s ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy, March 9, 2024 /PRNewswire/ — Medtronic plc. (NYSE: MDT), a global leader in healthcare technology, today…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.